Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by De Santis et al .

Authors :: Ramiro S
Mostard RLM
Landewé RBM
Source :: Annals of the rheumatic diseases [Ann Rheum Dis] 2023 May; Vol. 82 (5), pp. e112. Date of Electronic Publication: 2021 Feb 16.
Publication Year :: 2023
Abstract: Competing Interests: Competing interests: None declared.

Subjects :: Humans
Glucocorticoids therapeutic use
Cytokine Release Syndrome drug therapy
Cytokine Release Syndrome etiology
COVID-19 Drug Treatment
Treatment Outcome
COVID-19

Full Text Access

Tools